Copyright © Accurexa Inc. All rights reserved.
UCSF: University of California, San Francisco
Accurexa is a biotechnology company focused on targeted delivery of therapies to affected areas of a patient's body through the use of innovative technologies. We advance the development of our therapies through collaborations with universities (Johns Hopkins University) and other Biotech companies (DelMar Pharmaceuticals) in order to broaden our capabilities cost-efficiently.
We actively develop new neurological therapies and overcome the limitations of the blood-brain barrier by the application of direct delivery technologies, such as our implantable ACX-31 local chemotherapy wafer for the treatment of brain cancer.